Anzeige
Erschienen in:
01.04.2019 | Original Article
Outcomes and risk factors after adjuvant surgical treatments for Mycobacterium avium complex lung disease
Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 4/2019
Einloggen, um Zugang zu erhaltenAbstract
Background
Limited information is currently available on the postoperative outcomes of Mycobacterium avium complex lung disease (MAC-LD).
Objective
To show the outcomes of pulmonary resection and identify risk factors after adjuvant surgical treatments for MAC-LD.
Methods
One hundred and eight patients underwent adjuvant lung resection for MAC-LD at two hospitals between January 2008 and July 2016. We retrospectively evaluated outcomes and risk factors.
Results
Postoperative complications occurred in 14 patients (13%). After lung resection, 98 out of 108 patients (91%) achieved sputum culture conversion, eight (8.2%) of whom developed microbiological recurrence during the follow-up period. As a result, the success rate of adjuvant surgical treatments for MAC-LD with drug resistance was 83%. A multivariable analysis showed that a longer period from the initial medical treatment to surgery (hazard ratio, 1.01; 95% confidence interval, 1.00–1.02; p = 0.008) was independently associated with an increased risk of unfavorable outcomes after adjuvant surgery.
Conclusions
Adjuvant surgical treatments for MAC-LD have acceptable outcomes. Better control of the disease may be achieved in some patients with drug resistance and indications for surgery through surgical treatments, and pulmonary resection needs to be performed earlier rather than continuing chemotherapy in these patients because it reduces unfavorable outcomes.